Tango Therapeutics (TNGX) Assets (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Assets of $435.8 million for Q1 2026, up 58.87% year-over-year from $274.3 million in Q1 2025, and up 9.31% quarter-over-quarter from $398.7 million in Q4 2025.
Tango Therapeutics (TNGX) Assets (2020 - 2026) Analysis & Trends
Tango Therapeutics' Assets history runs 7 years deep, the most recent figure standing at $435.8 million for Q1 2026.
- In Q1 2026, Assets rose 58.87% year-over-year to $435.8 million; the TTM figure through Mar 2026 stood at $435.8 million (up 58.87% YoY), while the FY2025 annual figure was $398.7 million, up 25.97% from the prior year.
- Assets for Q1 2026 stood at $435.8 million, up from $398.7 million in the prior quarter.
- The five-year high for Assets was $471.5 million in Q1 2022, with the low at $210.1 million in Q3 2025.
- The 5-year median for Assets is $402.6 million (2023), against an average of $379.3 million.
- The sharpest annual moves came in 2022 and 2025: Assets jumped 180.23% in 2022, then tumbled 40.37% in 2025.
- Tango Therapeutics' Assets stood at $436.5 million in 2022, then fell by 7.77% to $402.6 million in 2023, then declined by 21.38% to $316.5 million in 2024, then rose by 25.97% to $398.7 million in 2025, then advanced by 9.31% to $435.8 million in 2026.
- Business Quant data shows TNGX's Assets at $435.8 million in Q1 2026, $398.7 million in Q4 2025, and $210.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | 1.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Bn |
| Mar 31, 2026 | 435.79 Mn |
| Dec 31, 2025 | 398.69 Mn |
| Sep 30, 2025 | 210.14 Mn |
| Jun 30, 2025 | 237.89 Mn |
| Mar 31, 2025 | 274.31 Mn |
| Dec 31, 2024 | 316.49 Mn |
| Sep 30, 2024 | 352.42 Mn |
| Jun 30, 2024 | 381.45 Mn |
| Mar 31, 2024 | 406.22 Mn |
| Dec 31, 2023 | 402.57 Mn |
| Sep 30, 2023 | 428.19 Mn |
| Jun 30, 2023 | 379.33 Mn |
| Mar 31, 2023 | 403.77 Mn |
| Dec 31, 2022 | 436.47 Mn |
| Sep 30, 2022 | 464.16 Mn |
| Jun 30, 2022 | 448.40 Mn |
| Mar 31, 2022 | 471.53 Mn |
| Dec 31, 2021 | 500.16 Mn |
| Sep 30, 2021 | 530.14 Mn |